High-affinity SOAT1 ligands remodeled cholesterol metabolism program to inhibit tumor growth.

Abstract

BACKGROUND:

Although cholesterol metabolism is a common pathway for the development of antitumor drugs, there are no specific targets and drugs for clinical use. Here, based on our previous study of sterol O-acyltransferase 1 (SOAT1) in hepatocelluar carcinoma, we sought to screen an effective targeted drug for precise treatment of hepatocelluar carcinoma and, from the perspective of cholesterol metabolism, clarify the relationship between cholesterol regulation and tumorigenesis and development.

METHODS:

In this study, we developed a virtual screening integrated affinity screening technology for target protein drug screening. A series of in vitro and in vivo experiments were used for drug activity verification. Multi-omics analysis and flow cytometry analysis were used to explore antitumor mechanisms. Comparative analysis of proteome and transcriptome combined with survival follow-up information of patients reveals the clinical therapeutic potential of screened drugs.

RESULTS:

We screened three compounds, nilotinib, ABT-737, and evacetrapib, that exhibited optimal binding with SOAT1. In particular, nilotinib displayed a high affinity for SOAT1 protein and significantly inhibited tumor activity both in vitro and in vivo. Multi-omics analysis and flow cytometry analysis indicated that SOAT1-targeting compounds reprogrammed the cholesterol metabolism in tumors and enhanced CD8+ T cells and neutrophils to suppress tumor growth.

CONCLUSIONS:

Taken together, we reported several high-affinity SOAT1 ligands and demonstrated their clinical potential in the precision therapy of liver cancer, and also reveal the potential antitumor mechanism of SOAT1-targeting compounds.

• Authors: Zhihua Wang, Miaomiao Wang, Mengxin Zhang, Kaikun Xu, Xinshuai Zhang, Yi Xie, Yiming Zhang, Cheng Chang, Xiaolu Li, Aihua Sun, Fuchu He
• Journal: BMC medicine (BMC Med) Vol. 20 Issue 1 Pg. 292 (08 09 2022) ISSN: 1741-7015 [Electronic] England
• PMID: 35941608 (Publication Type: Journal Article)
• Copyright: © 2022. The Author(s).

Chemical References

• Cholesterol
• Sterol O-Acyltransferase
• sterol O-acyltransferase 1

Topics

• CD8-Positive T-Lymphocytes
• Carcinoma
• Cholesterol (metabolism)
• Humans
• Sterol O-Acyltransferase (chemistry, metabolism)